Pharma Pulse 8/21/24: Utilizing AI Behind the Counter, A $3 Million Gene-Therapy Maker at a Bargain Price & more

Utilizing Artificial Intelligence Behind the Counter

In this part of his Pharma Commerce video interview, Matt Hawkins, CaryHealth’s Chief Technology Officer, explains the value of AI in the pharmacy environment.

The Role of Site Management Organizations in Clinical Trial Management

SMOs offer a range of services, including site selection, patient recruitment, data management, regulatory compliance, and quality assurance.

A $3 Million Gene-Therapy Maker at a Bargain Price

Sarepta’s treatment for Duchenne muscular dystrophy should become a blockbuster next year.

Organon & Lilly Expand Migraine Commercialization Agreement to 11 Additional Markets

The agreement builds on Organon’s global product portfolio for conditions that impact women disproportionately. Women are three times more likely to experience migraine than men.

Doceree on LinkedIn

Our Founder & CEO, Harshit Jain shares his expert advice on why life science marketers need to build a strategy around Point of Care messaging in a feature of Pharmaceutical Executive. 🎙️🌐

As life sciences marketers integrate digital channels into their brand strategies, aligning with overall business goals is crucial. Pharmaceutical managers must provide vision and direction, ensuring the right resources, techniques, and channels are in place to create an impact and set clear performance benchmarks. 🎯

Here’s why POC needs to be included in your brand strategy, read more: https://lnkd.in/deYqmMea

#HealthcareInnovation #Omnichannel #Healthtech #DigitalHealth #Pharma

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs